Variation in Adherence Measures to Imatinib Therapy
Uday Yanamandra(Army Hospital Research and Referral), Subhash Varma(Post Graduate Institute of Medical Education and Research), Kamal Kant Sahu(Post Graduate Institute of Medical Education and Research), Alka Khadwal(Post Graduate Institute of Medical Education and Research), Deepesh Lad(Post Graduate Institute of Medical Education and Research), Pankaj Malhotra(Post Graduate Institute of Medical Education and Research), Neelam Varma(Nagpur Institute of Technology), Neha Saini(Post Graduate Institute of Medical Education and Research), Savita Kumari(Post Graduate Institute of Medical Education and Research), Pooja Chauhan(Post Graduate Institute of Medical Education and Research), Vikas Suri(Post Graduate Institute of Medical Education and Research), Gaurav Prakash(Post Graduate Institute of Medical Education and Research), Jasmeen Gill(Almas Hospital), Sushma Yanamandra(Almas Hospital), Deepika Rikhi(Almas Hospital)
Cited by 7
Related Papers
Global Burden of Multiple Myeloma
|JAMA Oncology|2018|631
X-Linked Dyskeratosis Congenita Is Predominantly Caused by Missense Mutations in the DKC1 Gene
|The American Journal of Human Genetics|1999|264
Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis – Case report and systematic review
|Journal of Infection|2008|114
Imatinib has adverse effect on growth in children with chronic myeloid leukemia
|Pediatric Blood & Cancer|2011|95
Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF‐1 axis
|Pediatric Blood & Cancer|2013|85